Inventor · disambiguated record
Wayne Koff
Also filed as: KOFF WAYNE · KOFF WAYNE C
25 granted patents·6 pending applications·113 citations·filing 2000–2025
95Inventor score
Files withTHERACLONE SCIENCES INC12INT AIDS VACCINE INITIATIVE9HUMAN VACCINES PROJECT2INT AIDS VACCINE INITIATIVE INC2KOFF WAYNE C2
Top patents by PatentIndex Score
31 records- 0196US12410243B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2023·Granted Sep 9, 2025·2 cites·16 claims
- 0296US10087239B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2016·Granted Oct 2, 2018·14 cites·7 claims
- 0395US9464131B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2013·Granted Oct 11, 2016·18 cites·4 claims
- 0493USRE50268EBroadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2022·Granted Jan 14, 2025·2 cites·30 claims
- 0593US10093720B2Broadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2015·Granted Oct 9, 2018·12 cites·6 claims
- 0692US9051362B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityCHAN-HUI PO-YING·Filed 2010·Granted Jun 9, 2015·14 cites·20 claims
- 0791US12312396B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2024·Granted May 27, 2025·0 cites·32 claims
- 0891US11319362B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2019·Granted May 3, 2022·3 cites·44 claims
- 0990US6531313B1Invasive bacterial vectors for expressing alphavirus repliconsINT AIDS VACCINE INITIATIVE·Filed 2000·Granted Mar 11, 2003·27 cites·45 claims
- 1087USRE49037EBroadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Apr 19, 2022·3 cites·23 claims
- 1186US12018067B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2023·Granted Jun 25, 2024·0 cites·29 claims
- 1285US10865234B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Dec 15, 2020·1 cites·7 claims
- 1385US8586056B2HIV-1 envelope glycoproteinPHOGAT SANJAY K·Filed 2011·Granted Nov 19, 2013·14 cites·8 claims
- 1483US10836811B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2017·Granted Nov 17, 2020·1 cites·4 claims
- 1581US10407493B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Sep 10, 2019·1 cites·20 claims
- 1679US11845789B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2021·Granted Dec 19, 2023·0 cites·15 claims
- 1778US2025320281A1Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2025·Application pending·0 cites
- 1876US11584789B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2020·Granted Feb 21, 2023·0 cites·31 claims
- 1974US8105600B2Method of inducing high-titer neutralizing antibody responses in a host by administering immune complexes comprising anti-HIV-1 Env antibodies and the HIV-1 EnvKOFF WAYNE C·Filed 2008·Granted Jan 31, 2012·1 cites·8 claims
- 2069US10239934B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2018·Granted Mar 26, 2019·0 cites·14 claims
- 2163US10894080B2Transgenic VERO-CD4/CCR5 cell lineINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Jan 19, 2021·0 cites·8 claims
- 2261US10279027B2Transgenic Vero-CD4/CCR5 cell lineINT AIDS VACCINE INITIATIVE·Filed 2017·Granted May 7, 2019·0 cites·11 claims
- 2360US9920111B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2015·Granted Mar 20, 2018·0 cites·8 claims
- 2460US9382311B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Jul 5, 2016·0 cites·8 claims
- 2559US9796774B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Oct 24, 2017·0 cites·5 claims
- 2654US9925258B2Replication-competent VSV-HIV Env vaccinesINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Mar 27, 2018·0 cites·10 claims
- 2752US2022313816A1Compositions and methods for antibody-as-adjuvant vaccines and therapeuticsHUMAN VACCINES PROJECT·Filed 2022·Application pending·0 cites
- 2850US2008102073A1Antigen-Antibody Complexes as HIV-1 VaccinesKOFF WAYNE·Filed 2007·Application pending·0 cites
- 2949US2003170211A1Invasive bacterial vectors for expressing alphavirus repliconsFiled 2003·Application pending·0 cites
- 3049US2012258124A1Antigen-antibody complexes as hiv-1 vaccinesKOFF WAYNE C·Filed 2012·Application pending·0 cites
- 3138US2021325369A1Predictive biomarkers for an immune responseHUMAN VACCINES PROJECT·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wayne Koff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →